돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 43551생성일: 2026년 10월 24일

Tetrahydro-4H-pyran-4-one → Ethyl cis(+/-)-2-[4-{[(4-chloro-5-ethyl-1H-imidazol-2-yl)carbonyl]amino}-3-(tetrahydro-2H-pyran-4-ylamino)piperidin-1-yl]-1,3-benzothiazole-7-carboxylate

https://huagongshe.com/ko/reaction/43551

반응식

참여 물질

역할이름HCID투입량
반응물Tetrahydro-4H-pyran-4-oneHCID 121599—
반응물Sodium triacetoxyborohydrideHCID 5049666—
반응물Ethyl cis(+/-)-2-(3-amino-4-{[(4-chloro-5-ethyl-1H-imidazol-2-yl)carbonyl]amino}piperidin-1-yl)-1,3-benzothiazole-7-carboxylateHCID 86648558—
생성물Ethyl cis(+/-)-2-[4-{[(4-chloro-5-ethyl-1H-imidazol-2-yl)carbonyl]amino}-3-(tetrahydro-2H-pyran-4-ylamino)piperidin-1-yl]-1,3-benzothiazole-7-carboxylateHCID 8664856854%

반응 단계

The same operation as in Example (77d) was performed using ethyl cis(±)-2-(3-amino-4-{[(4-chloro-5-ethyl-1H-imidazol-2-yl)carbonyl]amino}piperidin-1-yl)-1,3-benzothiazole-7-carboxylate obtained by the method described in Example (81e) (30 mg, 0.063 mmol), tetrahydro-4H-pyran-4-one (0.11 mL, 1.19 mmol) and sodium (triacetoxy)borohydride (238 mg, 1.12 mmol), to obtain 19.1 mg of the title compound as a white solid (54%).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08536197B2
출처 데이터셋uspto-grants-2013_09
ORD IDord-baa3cf43cf664a8ba0eb6c2af5f79057
출처 메모uspto-grants-2013_09